VNRX — Volitionrx Ltd · rev $1.4M

Volitionrx Ltd (VNRX) is a medical devices company listed on AMEX.

Latest reported VNRX revenue for 2026-06-30 was $1.4M. Net income was -$14.0M. Revenue was up 40.5% from 2026-03-31 to 2026-06-30. VNRX currently screens at market cap $15.9M.

Use this VNRX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the VNRX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the VNRX SEC filings page. Lician reads the product cache first so this HTML stays unique to Volitionrx Ltd even when a live quote feed is slow.

Volitionrx Ltd latest statements (FY2025)

Latest cached year on this hub. Full VNRX income, balance, and cash tables.

  • Revenue$1.7M
  • Net Income-$23.4M
  • Total Assets$6.9M
  • Total Debt$0
  • Free Cash Flow-$19.8M

VNRX recent filings